Holen Sie sich die Stockscreener-App
6.082
1.30%
-0.088
Schlusskurs vom Vortag:
$6.17
Offen:
$6.24
24-Stunden-Volumen:
32,871
Relative Volume:
0.10
Marktkapitalisierung:
$137.68M
Einnahmen:
$52.55M
Nettoeinkommen (Verlust:
$-23.69M
KGV:
-6.4702
EPS:
-0.94
Netto-Cashflow:
$-15.29M
1W Leistung:
+0.83%
1M Leistung:
-13.25%
6M Leistung:
-10.83%
1J Leistung:
+85.11%
1-Tages-Spanne:
$6.06
$6.75
1-Wochen-Bereich:
$5.74
$6.75
52-Wochen-Spanne:
$2.76
$12.23
Exagen Inc Stock (XGN) Company Profile
Firmenname
Exagen Inc
Sektor
Branche
Telefon
(760) 560-1501
Adresse
1261 LIBERTY WAY, VISTA, CA
Vergleichen Sie XGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
6.075 | 139.83M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
612.51 | 227.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.66 | 165.99B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
710.57 | 56.89B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.68 | 41.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
245.55 | 41.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-11 | Eingeleitet | B. Riley Securities | Buy |
| 2025-07-30 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-23 | Eingeleitet | Craig Hallum | Buy |
| 2022-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-04-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-06-02 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cowen | Outperform |
| 2019-10-14 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Exagen Inc Aktie (XGN) Neueste Nachrichten
Why Exagen Inc. stock could rally in 2025Forecast Cut & Real-Time Sentiment Analysis - ulpravda.ru
What margin trends mean for Exagen Inc. stockMarket Growth Review & Long-Term Safe Return Strategies - ulpravda.ru
Will Exagen Inc. stock outperform Dow Jones indexJuly 2025 Catalysts & Long-Term Safe Return Strategies - ulpravda.ru
Will Exagen Inc. (E08A) stock split increase liquidityEarnings Risk Report & Stepwise Trade Signal Implementation - ulpravda.ru
Can Exagen Inc. (E08A) stock reach $200 price targetWeekly Gains Report & Community Consensus Picks - ulpravda.ru
Will Exagen Inc. stock benefit from AI adoption2025 Volatility Report & Verified Short-Term Plans - ulpravda.ru
What makes Exagen Inc. stock attractive to growth fundsWeekly Stock Summary & Low Risk High Reward Trade Ideas - ulpravda.ru
How Exagen Inc. stock reacts to job market dataTrade Execution Strategies & Free Rapid Portfolio Appreciation - ulpravda.ru
Why Exagen Inc stock could rally in 2025Market Risk Analysis & Real-Time Price Movement Reports - moha.gov.vn
Exagen Inc E08A Stock Analysis and ForecastTrendline Breakouts & Compound Your Gains With Quality Stocks - earlytimes.in
Will Exagen Inc. stock see PE expansionFibonacci Extensions & Build Wealth With Strategy - bollywoodhelpline.com
Will Exagen Inc. stock benefit from automationDividend Yield Trends & Technical + Fundamental = Smarter Investing - bollywoodhelpline.com
Aug Closing: How rising interest rates impact CZFS stockWeekly Market Outlook & Free Accurate Trade Setup Notifications - moha.gov.vn
How the Narrative Surrounding Exagen Is Evolving After New Guidance and Price Target Upgrades - Yahoo Finance
Exagen Inc. (NASDAQ:XGN) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
What Wall Street predicts for Exagen Inc. stock price2025 Pullback Review & Fast Entry Momentum Alerts - Улправда
Exagen Inc. (NASDAQ:XGN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Is Exagen Inc. (E08A) stock among top earnings playsQuarterly Market Summary & Trade Opportunity Analysis - DonanımHaber
Is Exagen Inc. stock dividend yield sustainable2025 Price Momentum & Entry and Exit Point Strategies - DonanımHaber
Can Exagen Inc. stock weather global recessionSwing Trade & Daily Technical Forecast Reports - DonanımHaber
Will Exagen Inc. (E08A) stock gain from green policiesJuly 2025 Sector Moves & Verified Momentum Watchlists - Улправда
Is Exagen Inc. stock trading at a premium valuationQuarterly Earnings Summary & Weekly Hot Stock Watchlists - Улправда
Is Exagen (NASDAQ:XGN) Using Debt Sensibly? - simplywall.st
Exagen Inc. (XGN) Alternative Data AnalyticsSocial & Digital Signals - Meyka
FourWorld Capital Management LLC Acquires Shares of 208,527 Exagen Inc. $XGN - MarketBeat
Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates - MSN
What New Catalysts Are Shaping the Narrative for Exagen? - Yahoo Finance
Comparing Fonar (NASDAQ:FONR) & Exagen (NASDAQ:XGN) - Defense World
Reviewing MacroGenics (NASDAQ:MGNX) & Exagen (NASDAQ:XGN) - Defense World
Will Exagen Inc. stock maintain dividend yield2025 Institutional Moves & Fast Exit and Entry Strategy Plans - Newser
Why Exagen Inc. (E08A) stock stays resilientWatch List & Daily Entry Point Trade Alerts - Newser
Is Exagen Inc. (E08A) stock good for wealth creationWeekly Trend Report & Daily Chart Pattern Signals - Newser
Is Exagen Inc. (E08A) stock protected from inflationTrade Volume Report & Free Technical Confirmation Trade Alerts - Newser
How Exagen Inc. (E08A) stock correlates with oil marketsQuarterly Profit Report & Expert Approved Momentum Trade Ideas - Newser
How higher bond yields impact Exagen Inc. (E08A) stockQuarterly Earnings Summary & Safe Entry Zone Identification - Newser
Is Exagen Inc. (E08A) stock supported by strong fundamentalsWeekly Trade Review & Verified Short-Term Plans - Newser
Exagen continues to execute on re-acceleration strategy, says Canaccord - TipRanks
Is Exagen Inc E08A a good long term investmentStock Market Trends & Free Realize Exceptional Returns - earlytimes.in
Exagen price target raised to $18 from $15 at B. Riley - MSN
Exagen Inc. (NASDAQ:XGN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Why Analysts Are Updating Exagen’s Story After Higher Targets and Growth Outlook - Yahoo Finance
Is Exagen Inc. (E08A) stock a momentum leaderMarket Sentiment Summary & Safe Entry Zone Tips - newser.com
Will Exagen Inc. stock split attract more investors2025 Growth vs Value & Daily Stock Trend Reports - newser.com
Is Exagen Inc. stock a contrarian buyProfit Target & Daily Oversold Stock Bounce Ideas - newser.com
Exagen (XGN) Price Target Increased by 17.39% to 15.74 - MSN
Finanzdaten der Exagen Inc-Aktie (XGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Exagen Inc-Aktie (XGN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Black Jeffrey G. | Chief Financial Officer |
Sep 02 '25 |
Sale |
9.79 |
20,466 |
200,362 |
269,026 |
| NMSIC Co-Investment Fund, L.P. | 10% Owner |
Mar 25 '25 |
Sale |
3.30 |
350,000 |
1,155,000 |
1,758,958 |
0.20%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):